Encompass Health Corporation (NYSE:EHC ) Q3 2023 Results Conference Call October 27, 2023 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President, CEO ...

Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects adjusted EPS to be within $3.41-$3.52 for 2023.

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key me...

Encompass Health's (EHC) Q3 results are likely to reflect improved inpatient volumes and bed additions, offset by higher operating expenses.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...

Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.

Here is how Encompass Health (EHC) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sector so far this year.

The Rehabilitation Hospital of Columbus is Encompass Health's (EHC) sixth location in the state of Georgia.

Here are the five stocks that meet our screening criteria - PRDO, EHC, OSK, HSBC and PHM.